Accès à distance ? S'identifier sur le proxy UCLouvain
Management of COVID-19-associated coagulopathy in persons with haemophilia.
Primary tabs
- Open access
- 398.32 K
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2021 |
Language | Anglais |
Journal information | "Haemophilia" - Vol. 27, no.1, p. 41-48 (2021) |
Peer reviewed | yes |
Publisher | Blackwell Science ((United Kingdom) Oxford) |
issn | 1351-8216 |
e-issn | 1365-2516 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/CARD - Pôle de recherche cardiovasculaire UCL - (SLuc) Service d'hématologie |
MESH Subject | Antibodies, Bispecific ; Antibodies, Monoclonal, Humanized ; Anticoagulants ; COVID-19 ; Disease Management ; Disseminated Intravascular Coagulation ; Factor IX ; Factor VIII ; Hemophilia A ; Heparin, Low-Molecular-Weight ; Humans |
Keywords | COVID-19 ; Clotting factor concentrates ; Coagulopathy ; Emicizumab ; Haemophilia ; Thromboprophylaxis |
Links |
Bibliographic reference | Pipe, Steven W ; Kaczmarek, Radoslaw ; Srivastava, Alok ; Pierce, Glenn F ; Makris, Mike ; et. al. Management of COVID-19-associated coagulopathy in persons with haemophilia.. In: Haemophilia, Vol. 27, no.1, p. 41-48 (2021) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/244797 |